Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-04
2009-10-27
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S113000
Reexamination Certificate
active
07608627
ABSTRACT:
A compound represented by the formulawherein R1, R2, R3and R6are the same or different and each is a hydrogen atom or a substituent; one of R4and R5is a hydrogen atom and the other is a group represented by the formula: —C(═X)—R7wherein X is N—O—R8or N—NH—R9wherein R8and R9are the same or different and each is a hydrogen atom or a group bonded via a carbon atom; and R7is a hydrogen atom or a substituent, and the like and a salt thereof have a superior IκB kinase inhibitory activity, and useful as pharmaceutical agents such as agents for preventing or treating diabetes and the like.
REFERENCES:
patent: 5919783 (1999-07-01), Chambers et al.
patent: 2004/0266823 (2004-12-01), Cumming et al.
Donadelli Roberta et al., Journal of the American Society of Nephrology : JASN, (Oct. 2003) vol. 14, No. 10, pp. 2436-2446.
Frydman et al., Journal of Organic Chemistry (1968), 33(10), 3762-6.
Frydman et al., Journal of the American Chemical Society (1965), 87(15), 3530-1.
Frydman et al., Journal of the American Chemical Society (1969), 91(9), 2338-42.
Fisher et al., Journal of Heterocyclic Chemistry (1969), 6(5), 775-6.
Clark et al., Journal of the Chemical Society [Section] C: Organic (1970), (3), 498-501. C.
Chambers et al. “Preparation of N-(indolinylakyl)piperazines as 5-HT1Dα receptor agonists”, Chemical Abstracts No. 125:33675.
F. J. Leeper et al., “Synthesis of Analogues of Porphobilinogen”, J. Chem. Soc., Perkin Trans 1., pp. 2633-2642, 1996 & CA 126:103943 (Abstract).
A. R. Battersby et al., “Biosynthesis of Porphyrins and Related Macrocytes. Part I. Synthesis of14C-Labelled Pyrromethaness”, J. Chem. Soc., Perkin 1, pp. 1546-1556, 1973.
F. J. Leeper et al., “Synthesis of Analogues Porphobilinogen”, Chemical Abstracts No. 126:103943 (1996).
Horiguchi Yoshiaki
Imoto Hiroshi
Wolf Mark A.
Rahmani Niloofar
Seaman D. Margaret
Takeda Pharmaceutical Company Limited
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
6-azaindole compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-azaindole compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-azaindole compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4141162